FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Whitepapers

The Whitepapers library on FierceBiotech.com contains whitepapers, case studies and research briefs on issues affecting biotechnology, including research and development, marketing and regulation.

If you would like to submit a whitepaper to the library, please visit the following link: Contact our advertising team



Point Of Care Testing in Clinical Trials

Source: 
http://www.woodleyequipment.com/clinicaltrial/news/133
Author: 
Mike Wickham, Dave McComas and Charlotte Wickham

This whitepaper outlines the use of Point Of Care (POC) testing in Clinical Trials, including the policies and procedures involved and the benefits POC can bring to trials across the globe. Point Of

... Read more...

From H1N1 and Beyond: Growing The Flu Vaccine Pipeline

Source: 
Quintiles
When the H1N1 pandemic appeared in early 2009, it was a global nightmare. But advances in disease surveillance and vaccine production technology enabled the scientific and medical communities to... Read more...

Patient Recruitment: Road to Success or Driving in Circles

Source: 
Industry Standard Research
Author: 
Kevin Olson
What should be available to the industry is a 360 degree assessment of the performance, drivers, motivations, hesitations, and leading edge techniques of patients, investigators, pharmaceutical... Read more...

Biotechnology Industry Pulse

Source: 
Primary Market Research
Author: 
Kevin Olson
This free primary market research report is based on the findings from 112 biotechnology executives and clinical development decision-makers at biotechnology companies. All the data is revealed and... Read more...

Taking a Commercial Approach to Drug Development - Target Product Profile Development and New Product Strategic Planning For Bio

Source: 
Pharmacision
Explore Target Product Profile development and commercially driven drug development strategies for biotech and drug development companies. In this presentation by Thomas Marten, founder of... Read more...

New Drug Opportunity Assessment Process -- Creating Strategic Planning Tools for Future Product Commercial Success

Source: 
Pharmacision
Pharmaceutical and biotech Business Development, Marketing and Strategic Planning Groups need an early read on opportunities, but oftentimes don’t have time or budget for extensive market... Read more...

Don't Trust Your Gut, It Lies! The Value of an Opportunity Assessment Strategy

Source: 
Pharmacision
Oftentimes small pharma and biotech companies make key licensing and portfolio development decisions with limited data or poor information due to the high costs of conducting large scale market... Read more...

Enterprise 2.0: Are you ready for the revolution?

Source: 
IQ Business Group
Author: 
Michael D. Beck
Technological advancements and social media tools are transforming the world in a way we never thought possible just a few short decades ago. Easy access to a wide variety of information and the... Read more...

Biotech CRO Benchmarking

Source: 
ISR - Industry Standard Research
Author: 
Kevin Olson

This is an executive summary of a substantial market research study based on interviews with 44 biotechnology company representatives, rating 130 unique projects with CROs. Respondents graded 10

... Read more...

First Report on Results of US Phase 2 Clinical Study of Intranasal Granisetron

Source: 
Shin Nippon Biomedical Laboratories, Ltd. (SNBL)
Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is developing an intranasal form of the antiemetic drug granisetron (development code: TRG) in the US. SNBL today announces the first report on the... Read more...

Back to Basics: Tax Merger & Acquisition Issues within the Life Science Industry

Source: 
RSM McGladrey
Author: 
John Lanza and Kwajo Sarfoh

The life sciences industry comprises companies operating within various business segments, including pharmaceuticals and medical supplies (biotechs), devices and equipment. According to First Data,

... Read more...

Outsourcing Biomaterials Management – Preservation in a Downturn

Source: 
Kryosphere, Inc.
Author: 
Douglas S. Baker, L. Eric Hallman, and A. Neil Jones
Biomaterials represent intellectual property. Intellectual property provides the basis for investors to place their resources at risk and is an integral part of value creation. Preservation is... Read more...

Oncology Sales Success: It's All About the Patient

Source: 
Health Strategies Group
Every medical specialty is different, requiring a different sales approach based on each specialty's needs and values. Learn about the behaviors, knowledge and support that increase sales... Read more...

Personalized Medicine: Closer to Reality?

Source: 
Enterprise Florida
Author: 
John Carroll, FierceBiotech editor
Personalized medicine is considered to be the future of healthcare. Yet, little specific information is available on how it will affect drug developers, healthcare professionals and patients. Learn... Read more...

Thought Leader Training

Source: 
Cutting Edge Information
Author: 
Jordan Stone

With increased public and governmental concern, physicians' relationships with the pharmaceutical industry seem to receive ever-escalating scrutiny from both regulatory bodies and state legislators.

... Read more...